Veterinary Medicine Information website

FLUMEXIL 100 mg/g, granules for use in the drinking water or liquid feed for calves, buffalo calves, foals, lambs, kid-goats, swine and piglets, rabbits, chickens

Authorised
  • Flumequine
Download as PDF

Product identification

Medicine name:
FLUMEXIL 100 mg/g, granules for use in the drinking water or liquid feed for calves, buffalo calves, foals, lambs, kid-goats, swine and piglets, rabbits, chickens
Active substance:
  • Flumequine
Target species:
  • Buffalo
  • Chicken
  • Cattle (calf)
  • Goat
  • Sheep (lamb)
  • Rabbit
  • Pig (piglet)
  • Horse (foal)
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Flumequine
    100.00
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Granules for oral solution
Withdrawal period by route of administration:
  • Oral use
    • Buffalo
      • Meat and offal
        8
        day
    • Chicken
      • Meat and offal
        6
        day
    • Cattle (calf)
      • Meat and offal
        8
        day
    • Goat
      • Meat and offal
        8
        day
    • Sheep (lamb)
      • Meat and offal
        8
        day
    • Rabbit
      • Meat and offal
        6
        day
    • Pig (piglet)
      • Meat and offal
        8
        day
    • Horse (foal)
      • Meat and offal
        8
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01MB07
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Cyprus
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Fatro S.p.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Fatro S.p.A.
Responsible authority:
  • Veterinary Services, Ministry Of Agriculture, Natural Resources And Environment
Authorisation number:
  • 14564
Date of authorisation status change:

Documents

Summary of Product Characteristics

English (PDF)
Published on: 8/07/2022
Download